Why Juniper
Juniper is the world’s first clinical embryo test that uses both whole genome trios and transcriptome sequencing.
While other platforms that claim to be whole genome only report on 5-10% of the genes in the genome, we analyze millions of variants in every embryo across the entire genome.
It’s the most detailed and accurate embryo data in human history to improve IVF outcomes.
A new standard of care in PGT.
Most current embryo screening methods can only detect chromosome-level issues, which only account for about 50% of IVF failures and pregnancy losses.
At Juniper, we take the most comprehensive approach. Our test provides everything you’d get from aneuploidy testing (PGT-A) and most monogenic testing (PGT-M)—and then some. We also screen for thousands of genetic changes linked to IVF failure, pregnancy loss, and serious medical conditions after birth. We’re focused on the outcomes that matter most.
- Fewer false positives
- Screening for nearly every known monogenic disorder
- Successful pregnancy, sooner
With this deeper insight, we can detect embryo-specific issues that account for over 85% of IVF failures and pregnancy losses. That means fewer failed transfers, faster paths to pregnancy, and fewer emotional and physical hurdles along the way.
| Juniper PGT | PGT-WGS | PGT-P (Polygenic Risk Scores) | PGT-A (Aneuploidy) |
|---|---|---|---|
| >9,000,000,000 data points | 3,000,000,000 data points | <1,000 data points | 46 data points (23 chromosome pairs) |
| All PGT-A and PGT-M findings and looks for individual genetic changes that directly cause pregnancy loss and ~6,000 genetic diseases | Looks for individual genetic changes that cause ~1,000 genetic diseases plus PGT-A findings | Looks for patterns of changes that are associated with relative risk of ~600 traits, including some diseases | Looks for whether the embryo has the correct number of chromosomes |
| Uses parental (trio) data to help ensure consistency regardless of patient ancestry | Developed primarily from people with European ancestry | Developed primarily from people with European ancestry | Consistent data regardless of patient ancestry |
| Identifies causes for at least 85% of adverse pregnancy outcomes | Identifies causes for ~50% of adverse pregnancy outcomes | Does not identify causes of pregnancy outcomes | Identifies causes for ~50% of adverse pregnancy outcomes |
| Identifies causes for over 6,000 genetic diseases | Identifies causes for ~1,000 genetic diseases | Does not identify causes of diseases | PGT-M can only identify the cause of 1 disease at a time and only if parents are affected or carriers |
Juniper PGT empowers confident, ethical choices about embryo implantation — choices that feel right because they’re guided by rigorous science.
We use the same clinical workflow as all existing embryo testing and deliver straightforward answers in clear reports. We provide genetic counseling support before and after testing, helping parents and providers interpret results and plan next steps with confidence and care.
Learn more about our testing, technology, and more at the links below.